API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.biospace.com/article/releases/aslan-pharmaceuticals-enrolls-first-patient-in-proof-of-concept-study-for-aslan004-targeting-atopic-dermatitis/
https://www.fiercebiotech.com/biotech/aslan-retools-csl-deal-taking-control-would-be-dupixent-rival
https://www.biospace.com/article/aslan-pharmaceuticals-acquires-full-global-commercial-rights-for-aslan004-from-csl/?s=79